Intra-articular injection of the anti-inflammatory compound LMWF-5A in adults with severe osteoarthritis: a double-blind prospective randomized controlled multi-center safety and efficacy trial

BACKGROUND: There are limited efficacious treatment options for severe osteoarthritis of the knee (OAK). The Low Molecular Weight Fraction of 5% human serum Albumin (LMWF-5A) is in development to treat severe OAK. This study evaluated the safety and efficacy of LMWF-5A for the signs and symptoms of...

Descripción completa

Detalles Bibliográficos
Autores principales: Salottolo, Kristin, Cole, Brian, Bar-Or, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985594/
https://www.ncbi.nlm.nih.gov/pubmed/29910837
http://dx.doi.org/10.1186/s13037-018-0158-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985594/
https://www.ncbi.nlm.nih.gov/pubmed/29910837
http://dx.doi.org/10.1186/s13037-018-0158-0

Ejemplares similares